| A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease M Bérard, R Sheta, S Malvaut, R Rodriguez-Aller, M Teixeira, W Idi, ... Plos Biology 20 (3), e3001578, 2022 | 13 | 2022 |
| Pharmacological functionalization of protein-based nanorobots as a novel tool for drug delivery in cancer O Tavassoly, I Tavassoly ACS Pharmacology & Translational Science 4 (4), 1463-1467, 2021 | 1 | 2021 |
| EGFR aggregation in the brain O Tavassoly, I Tavassoly ACS Chemical Neuroscience 12 (11), 1833-1834, 2021 | 4 | 2021 |
| Pharmacological inhibition of brain EGFR activation by a BBB-penetrating inhibitor, AZD3759, attenuates α-synuclein pathology in a mouse model of α-synuclein propagation O Tavassoly, E del Cid Pellitero, F Larroquette, E Cai, RA Thomas, ... Neurotherapeutics 18, 979-997, 2021 | 13 | 2021 |
| Optogenetic-Mediated Spatiotemporal Control of α-Synuclein Aggregation Mimics Lewy Body Formation and Triggers Neurodegeneration M Berard, R Sheta, S Malvaut, R Rodriguez-Aller, M Teixeira, W Idi, ... | 2 | 2021 |
| Pharmacological inhibition and knockdown of OGlcNAcase reduces cellular internalization of αsynuclein preformed fibrils O Tavassoly, J Yue, DJ Vocadlo The FEBS journal 288 (2), 452-470, 2021 | 35 | 2021 |
| Seeding brain protein aggregation by SARS-CoV-2 as a possible long-term complication of COVID-19 infection O Tavassoly, F Safavi, I Tavassoly ACS Chemical Neuroscience 11 (22), 3704-3706, 2020 | 64 | 2020 |
| Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection O Tavassoly, F Safavi, I Tavassoly Molecular pharmacology 98 (5), 612-619, 2020 | 41 | 2020 |
| Inhibition of brain epidermal growth factor receptor activation: a novel target in neurodegenerative diseases and brain injuries O Tavassoly, T Sato, I Tavassoly Molecular pharmacology 98 (1), 13-22, 2020 | 51 | 2020 |
| Optogenetic-Mediated Spatiotemporal Control of α-Synuclein Aggregation Disrupts Nigrostriatal Transmission and Precipitates Neurodegeneration M Bérard, R Sheta, S Malvaut, R Turmel, MJ Alpaugh, M Dubois, ... | 2 | 2019 |
| SMPD1 mutations, activity, and αsynuclein accumulation in Parkinson's disease RN Alcalay, V Mallett, B Vanderperre, O Tavassoly, Y Dauvilliers, RYJ Wu, ... Movement Disorders 34 (4), 526-535, 2019 | 107 | 2019 |
| Quinolinic acid amyloid-like fibrillar assemblies seed α-synuclein aggregation O Tavassoly, D Sade, S Bera, S Shaham-Niv, DJ Vocadlo, E Gazit Journal of molecular biology 430 (20), 3847-3862, 2018 | 54 | 2018 |
| Seeding of proteins into amyloid structures by metabolite assemblies may clarify certain unexplained epidemiological associations D Sade, S Shaham-Niv, ZA Arnon, O Tavassoly, E Gazit Open biology 8 (1), 170229, 2018 | 33 | 2018 |
| SMPD1 mutations, acid-sphingomyelinase activity and alpha-synuclein accumulation in Parkinson's disease Z Gan-Or, V Mallett, O Tavassoly, Y Dauvilliers, C Leblond, ... MOVEMENT DISORDERS 31, S220-S220, 2016 | | 2016 |
| Rasagiline, a suicide inhibitor of monoamine oxidases, binds reversibly to α-synuclein J Kakish, O Tavassoly, JS Lee ACS chemical neuroscience 6 (2), 347-355, 2015 | 29 | 2015 |
| The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease O Tavassoly, J Kakish, S Nokhrin, O Dmitriev, JS Lee European journal of medicinal chemistry 88, 42-54, 2014 | 41 | 2014 |
| Cu (II) and dopamine bind to αsynuclein and cause large conformational changes O Tavassoly, S Nokhrin, OY Dmitriev, JS Lee The FEBS journal 281 (12), 2738-2753, 2014 | 52 | 2014 |
| Single molecule studies of synuclein family of proteins and peptides with nanopores O Tavassoly University of Saskatchewan, 2014 | | 2014 |
| Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis O Tavassoly, JS Lee FEBS letters 586 (19), 3222-3228, 2012 | 54 | 2012 |
| Nanopore analysis: An emerging technique for studying the folding and misfolding of proteins CA Madampage, O Tavassoly, C Christensen, M Kumari, JS Lee Prion 6 (2), 116-123, 2012 | 54 | 2012 |
jeremy leeProfessor of Biochemistry, University of Saskatchewan在 usask.ca 的电子邮件经过验证
